BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25676841)

  • 1. Feasibility and accuracy of molecular testing in specimens obtained with small biopsy forceps: comparison with the results of surgical specimens.
    Oki M; Yatabe Y; Saka H; Kitagawa C; Kogure Y; Ichihara S; Moritani S
    Respiration; 2015; 89(3):235-42. PubMed ID: 25676841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS.
    Guisier F; Salaün M; Lachkar S; Lamy A; Piton N; Obstoy B; Sabourin JC; Thiberville L
    Respirology; 2016 May; 21(4):718-26. PubMed ID: 27099101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.
    Sánchez-Font A; Chalela R; Martín-Ontiyuelo C; Albero-González R; Dalmases A; Longarón R; Alonso-Espinaco V; Curull V; Bellosillo B; Pijuan L
    Cancer Cytopathol; 2018 Oct; 126(10):860-871. PubMed ID: 30291816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer.
    Yamada N; Oizumi S; Asahina H; Shinagawa N; Kikuchi E; Kikuchi J; Sakakibara-Konishi J; Tanaka T; Kobayashi K; Hagiwara K; Nishimura M
    Oncology; 2012; 82(6):341-6. PubMed ID: 22677909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.
    Rosenblum F; Hutchinson LM; Garver J; Woda B; Cosar E; Kurian EM
    Cancer Cytopathol; 2014 Nov; 122(11):810-21. PubMed ID: 25099128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic and molecular characterization of lung cancer with tissue obtained by electromagnetic navigation bronchoscopy.
    Ha D; Choi H; Almeida FA; Arrossi A; Brainard J; Cicenia J; Farver C; Gildea T; Machuzak MS; Mazzone P
    J Bronchology Interv Pulmonol; 2013 Jan; 20(1):10-5. PubMed ID: 23328135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
    Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer.
    Wang X; Chen S; Emerson RE; Wu HH; Cramer HM; Curless K; Chang HY; Zhang S; Randolph ML; Cheng L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):119-124. PubMed ID: 30688675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer.
    Sakamoto T; Kodani M; Takata M; Chikumi H; Nakamoto M; Nishii-Ito S; Ueda Y; Izumi H; Makino H; Touge H; Takeda K; Yamasaki A; Yanai M; Tanaka N; Igishi T; Shimizu E
    Int J Oncol; 2015 Apr; 46(4):1473-80. PubMed ID: 25651992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic management of transthoracic needle aspirates for histological subtyping and EGFR testing in patients with peripheral lung cancer: An institutional experience.
    Son C; Kang EJ; Roh MS
    Diagn Cytopathol; 2015 Jul; 43(7):532-8. PubMed ID: 25427228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transbronchial biopsy needle rinse solution used for comprehensive biomarker testing in patients with lung cancer.
    Sakairi Y; Sato K; Itoga S; Saegusa F; Matsushita K; Nakajima T; Yoshida S; Takiguchi Y; Nomura F; Yoshino I
    J Thorac Oncol; 2014 Jan; 9(1):26-32. PubMed ID: 24346091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suitability of computed tomography-guided biopsy specimens for subtyping and genotyping of non-small-cell lung cancer.
    Hsiao SH; Chung CL; Lee CM; Chen WY; Chou YT; Wu ZH; Chen YC; Lin SE
    Clin Lung Cancer; 2013 Nov; 14(6):719-25. PubMed ID: 23891241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy.
    Tsai TH; Yang CY; Ho CC; Liao WY; Jan IS; Chen KY; Wang JY; Ruan SY; Yu CJ; Yang JC; Yang PC; Shih JY
    Lung Cancer; 2013 Dec; 82(3):420-5. PubMed ID: 24183104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suitability of small bronchoscopic tumour specimens for lung cancer genotyping.
    Dooms C; Vliegen L; Vander Borght S; Yserbyt J; Hantson I; Verbeken E; Wauters E; Nackaerts K; Ninane V; Vansteenkiste J; Vandenberghe P
    Respiration; 2014; 88(5):371-7. PubMed ID: 25300340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.
    Bar J; Damianovich M; Hout Siloni G; Dar E; Cohen Y; Perelman M; Ben Nun A; Simansky D; Yellin A; Urban D; Onn A
    Clin Lung Cancer; 2014 Mar; 15(2):159-65. PubMed ID: 24370118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.
    Kobayashi M; Sakakibara T; Inoue A; Fukuhara T; Sasano H; Ichinose M; Nukiwa T
    Respir Investig; 2014 Jan; 52(1):49-56. PubMed ID: 24388371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forceps biopsy and suction catheter for sampling in pulmonary nodules and infiltrates.
    Peschke A; Wiedemann B; Höffken G; Koschel D
    Eur Respir J; 2012 Jun; 39(6):1432-6. PubMed ID: 22005922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
    Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T
    Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative approach to determining therapeutic choices in advanced non-small cell lung carcinoma (NSCLC): maximizing the diagnostic procedure and the use of low-volume lung biopsies.
    Lim EH; Zhang SL; Yu K; Nga ME; Ahmed DA; Agasthian T; Wong PS; Chua GC; Wong D; Tan L; Seto KY; Yap WS; Low SP; Khoo KL; Chang A; Ng A; Tan P
    J Thorac Oncol; 2007 May; 2(5):387-96. PubMed ID: 17473653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer.
    Haentschel M; Boeckeler M; Ehab A; Wagner R; Spengler W; Steger V; Boesmueller H; Horger M; Lewis RA; Fend F; Kanz L; Bonzheim I; Hetzel J
    Lung Cancer; 2020 Mar; 141():56-63. PubMed ID: 31955001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.